Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|August 29, 2023
Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1Adrian Schwarzer, Matheus Oliveira, Marc-Jens Kleppa, et al.
The New England Journal of Medicine|November 12, 2010
Stem-cell gene therapy for the Wiskott-Aldrich syndromeKaan Boztug, Manfred Schmidt, Adrian Schwarzer, et al.
Plos One|November 18, 2014
Cell fate decisions in malignant hematopoiesis: leukemia phenotype is determined by distinct functional domains of the MN1 oncogeneCourteney K Lai, Yeonsook Moon, Florian Kuchenbauer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 26, 2021
Predicting genotoxicity of viral vectors for stem cell gene therapy using gene expression-based machine learningAdrian Schwarzer, Steven R Talbot, Anton Selich, et al.
Haematologica|July 20, 2023
Fludarabine, cytarabine, and idarubicin with or without venetoclax in patients with relapsed/refractory acute myeloid leukemiaRabia Shahswar, Gernot Beutel, Razif Gabdoulline, et al.
Nature Communications|August 11, 2017
The non-coding RNA landscape of human hematopoiesis and leukemiaAdrian Schwarzer, Stephan Emmrich, Franziska Schmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2009
Clinical and immunologic effects of intranodal autologous tumor lysate-dendritic cell vaccine with Aldesleukin (Interleukin 2) and IFN-{alpha}2a therapy in metastatic renal cell carcinoma patientsThomas Schwaab, Adrian Schwarzer, Benita Wolf, et al.
Blood|August 20, 2013
Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AMLAnuhar Chaturvedi, Michelle Maria Araujo Cruz, Nidhi Jyotsana, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2018
Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid LeukemiaRaj Bhayadia, Kathrin Krowiorz, Nadine Haetscher, et al.
Hemasphere|December 29, 2021
Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working PartyJesse M Tettero, Sylvie Freeman, Veit Buecklein, et al.
Pageof 5